Inhibition of SIRT7 reversed MST1 levels and inhibited hepatocellular carcinoma (HCC) growth, demonstrating the SIRT7–MST1–YAP axis as a target (106). The gene discussed is SIRT7; the disease is hepatocellular carcinoma.